Pharmaceuticals

FDA Issues Draft Guidelines on Diversity of Clinical Trial Populations

bexib
By bexib 0 Min Read

This guidance is intended to assist sponsors in recruiting test populations that accurately represent real-world populations.

You Might Also Like

Solving prescription drug shortages: Q&A with Peter Ax

Pfizer’s Bourla confident about position of obesity drug despite delays

Pharma Pulse 8/1/24: Addressing the drug shortage crisis, Microsoft’s AI dream = expensive reality, and more

Antheia Announces $17 Million in Funding for Domestic Pharmaceutical Raw Materials Production

Lilly invests $1 billion in ‘biology first’ for obesity gene therapy

Share This Article
Previous Article New eCommerce Tools: June 27, 2024
Next Article Fungicide Strategies for Quality and Yield – RealAgriculture
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Progress of metal cutting technology: Innovative innovation, sustainability, and future labor
Manufacturing
Ceratizit showcases innovation, sustainability and cutting-edge solutions at IMTEX 2025
Manufacturing
Goldman launches an internal GEN AI Assistant with 10K employees
Banking
Taiwan emerges as key player in Indian machine tools market with 20.8% growth
Manufacturing